HEDIMED @ ICDS2022
Some of our key investigators took part in the 19th International Celiac Disease Symposium ICDS2022 in Sorrento, Italy. The symposium is the key forum for scientists, clinicians, health allied professionals, patient associations and industry to meet and exchange knowledge and improve cooperation across care and prevention of celiac disease.
The bi-annual meeting aims to mainstream celiac disease research and this time succeeded in gathering around 700 attendants. The HEDIMED project was represented by committed scientists Daniel Agardh (University of Lund) and Ketil Størdal (Norwegian Institute of Public Health) who had a leading role in the opening session of the meeting. Agardh in his part emphasized the role of exposome in the early development and pathogenesis of celiac disease, as well as introduced HEDIMED project to the scientific community working in this field.
Daniel Agardh presenting HEDIMED as an important milestone for the exposome approach in celiac disease research.
Another significant contribution for the meeting came on behalf of HEDIMED representative Kalle Kurppa (Tampere University), who, next to his work for celiac disease research in our consortium, acts as a committee member in the International Society for the Study of Celiac Disease (ISSCD). The received attention and interest for HEDIMED delighted all the attending partners!
Vitamin A intake during pregnancy and risk of offspring celiac disease by Nicolai Lund-Blix – All smiles in the poster session!
Having spread the message of aims and objectives of research in HEDIMED, we are also glad to announce that some study results of ours were presented by Nicolai Lund-Blix (Norwegian Institute of Public Health) in a poster session. The results will be presented in a more extensive paper soon, stay tuned!
Pictures: Nicolai Lund-Blix
